Intellia Therapeutics – Global Health Economics and Outcomes Research Postdoctoral Research Fellow

Northeastern University•Boston, MA

23h•$60,315 - $85,193•Hybrid

About The Position

Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program’s success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Health economics and outcomes research (HEOR) fellowship, based in Cambridge, MA. Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with severe diseases. The HEOR and Evidence Strategy team sits within the Market Access and Patient Services team in the Commercial Organization. At Intellia, a technical and scientific expertise background is highly valued. The Fellowship offers a uniquely structured experience, beginning with a foundational year working with the Director, HEOR and Evidence Strategy supporting the HEOR strategy for Intellia’s novel, gene-editing therapies. This foundational year provides the Fellow with a strong understanding of strategic development of value and evidence generation strategy to support clinical development and commercial brand plans. In the second year, the Fellow will have an option to participate in 1-3 projects / activities within the broader Market Access and Patient Services team. These optional activities will aim to give the Fellow exposure to key strategic or execution activities that fall within Field HEOR and Market Access Strategy. This will allow the Fellow to gain blended exposure across Intellia’s dynamic business functions and build a versatile skill set for a future in biotech.

Requirements

Doctor of Pharmacy (PharmD) degree from an ACPE-accredited institution
Eligible for pharmacist licensure in the State of Massachusetts
Excellent oral, written communication, medical writing skills
Strong scientific acumen, ability to simplify complex scientific data, and an interest in gene-editing and CRISPR
Strong time management and leadership abilities
Ability to work independently and take initiative on a variety of projects at both the industry site and Northeastern
Capability for hybrid or in-person work arrangement, with an expectation to be on-site at Intellia approximately 4 times per month, subject to team and project needs
Ability to travel to scientific conferences in the US or internationally per business needs

Nice To Haves

Elective study or experience related to Epidemiology/Outcomes Research/Health Economics, Statistics/Biostatistics, Real-world Evidence Research, etc. is a plus
Advanced degree (PhD/MS/MPH) in related fields like health economics and outcomes research, epidemiology, or public health is preferred

Responsibilities

DEVELOP in-depth knowledge of Intellia’s CRISPR gene editing technology, disease and treatment landscape of relevant therapeutic areas—to support strategic evidence generation to support the product value proposition
LEARN to execute global/US HEOR studies which span across the key scientific pillars including; Patient-focused drug development including patient-reported outcomes as key measures in clinical trials, Real-world evidence generation and analysis to identify unmet needs and inform comparative effectiveness, global epidemiology to support regulatory interactions and stakeholder disease education & awareness, Evidence synthesis with literature reviews and indirect/mixed treatment comparisons, Health economic models (cost effectiveness analysis and budget impact analysis), and target patient population tools (US intended use and ex-US target patient population), Global HEOR activities, In support of US launch – pre-approval information exchange (PIE) tools and post-approval value tools, Strategy and planning related to various country-specific health authority (HTA) interactions and reimbursement dossier development
SUPPORT or LEAD development of HEOR publications for scientific conferences and peer-reviewed journals; ensure the publication plans are up-to-date for HEOR studies
BE an active contributor by helping to executing HEOR tactics including management of external vendors helping with study execution
SUPPORT development of presentations for internal team meetings to drive cross-functional collaboration and discussion to improve the quality of the work
MANAGE HEOR external facing materials development and approval via Veeva PromoMats
Optional project experience with other functions of Market Access and Patient Services in year 2: Field HEOR: Partner with field teams to translate HEOR evidence into customer-facing value narratives and support scientific exchange with payers/providers, in collaboration with Payer Account Management team. Market Access Strategy: Contribute to cross-functional market access planning by assessing evidence gaps, evaluating payer landscape insights, and helping shape value propositions across key stakeholder segments.
PARTICIPATE in future fellowship recruitment activities and interviews